Notably, a number of patients with ITM could convert to other CIDDs at a later stage, such as multiple sclerosis (MS) and anti-aquaporin 4-positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD)5–7. This evidence concerns the gene AQP4 and myeloid sarcoma.